Plante Moran Financial Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-23
| Closed | -$8.72K | – | 778 |
|
|
2023
Q2 | $8.72K | Hold |
23
| – | – | ﹤0.01% | 564 |
|
|
2023
Q1 | $11K | Sell |
23
-13
| -36% | -$6.09K | ﹤0.01% | 550 |
|
|
2022
Q4 | $15.1K | Hold |
36
| – | – | ﹤0.01% | 517 |
|
|
2022
Q3 | $15K | Buy |
36
+3
| +9% | +$1.5K | ﹤0.01% | 512 |
|
|
2022
Q2 | $16K | Buy |
33
+10
| +43% | +$5.21K | ﹤0.01% | 509 |
|
|
2022
Q1 | $13K | Sell |
23
-6
| -21% | -$3.62K | ﹤0.01% | 562 |
|
|
2021
Q4 | $22K | Buy |
29
+6
| +26% | +$4.49K | ﹤0.01% | 536 |
|
|
2021
Q3 | $17K | Hold |
23
| – | – | ﹤0.01% | 592 |
|
|
2021
Q2 | $15K | Hold |
23
| – | – | ﹤0.01% | 611 |
|
|
2021
Q1 | $13K | Sell |
23
-3
| -12% | -$1.78K | ﹤0.01% | 606 |
|
|
2020
Q4 | $15K | Buy |
26
+3
| +13% | +$1.71K | ﹤0.01% | 570 |
|
|
2020
Q3 | $12K | Hold |
23
| – | – | ﹤0.01% | 575 |
|
|
2020
Q2 | $10K | Hold |
23
| – | – | ﹤0.01% | 517 |
|
|
2020
Q1 | $8K | Hold |
23
| – | – | ﹤0.01% | 517 |
|
|
2019
Q4 | $9K | Hold |
23
| – | – | ﹤0.01% | 553 |
|
|
2019
Q3 | $8K | Hold |
23
| – | – | ﹤0.01% | 622 |
|
|
2019
Q2 | $7K | Hold |
23
| – | – | ﹤0.01% | 600 |
|
|
2019
Q1 | $7K | Sell |
23
-6
| -21% | -$1.62K | ﹤0.01% | 589 |
|
|
2018
Q4 | $7K | Buy |
29
+6
| +26% | +$1.61K | ﹤0.01% | 544 |
|
|
2018
Q3 | $7K | Sell |
23
-6
| -21% | -$1.86K | ﹤0.01% | 546 |
|
|
2018
Q2 | $8K | Hold |
29
| – | – | ﹤0.01% | 566 |
|
|
2018
Q1 | $7K | Buy |
29
+21
| +263% | +$5.35K | ﹤0.01% | 657 |
|
|
2017
Q4 | $2K | Sell |
8
-3
| -27% | -$727 | ﹤0.01% | 780 |
|
|
2017
Q3 | $2K | Sell |
11
-3
| -21% | -$675 | ﹤0.01% | 714 |
|
|
2017
Q2 | $3K | Buy |
14
+5
| +56% | +$1.09K | ﹤0.01% | 710 |
|
|
2017
Q1 | $2K | Sell |
9
-32
| -78% | -$6.16K | ﹤0.01% | 784 |
|
|
2016
Q4 | $7K | Buy |
41
+3
| +8% | +$511 | ﹤0.01% | 642 |
|
|
2016
Q3 | $6K | Buy |
38
+4
| +12% | +$607 | ﹤0.01% | 650 |
|
|
2016
Q2 | $5K | Buy |
34
+1
| +3% | +$143 | ﹤0.01% | 620 |
|
|
2016
Q1 | $5K | Buy |
+33
| New | +$4.33K | ﹤0.01% | 574 |
|
Other funds holding BIO
VAM